Literature DB >> 9182895

Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID).

M L Johnson1, L G Keeton, Z B Zhu, J E Volanakis, M D Cooper, H W Schroeder.   

Abstract

The concentration of serum immunoglobulins in individuals with IgA deficiency (IgAD) and CVID can vary with age to have practical implications for evaluation, therapy, and genetic analysis. Most IgAD and CVID patients in our clinic population in the Southeastern United States have inherited part or all of two extended MHC haplotypes, referred to as haplotype 1 (HLA-DQB1 0201, HLA-DR3, C4B-Sf, C4A-0, G1-15, Bf-0.4, C2-a, HSP-7.5, TNF alpha-5, HLA-B8, HLA-A1) and haplotype 2 (HLA-DQB1 0201, HLA-DR-7, C4B-S, C4A-L, G11-4.5, Bf-0.6, C2-b, HSP-9, TNF alpha-9, HLA-B44, HLA-A29). In the present study, the clinic records of 68 CVID patients and 73 IgAD patients were reviewed to determine whether patients with familial or MHC-associated IgAD or CVID experience changes in serum immunoglobulin concentrations. An increase in serum immunoglobulin to the normal range was associated with clinical improvement in one patient with CVID and haplotype 2, two patients with IgAD and haplotype 2, and one IgAD patient whose haplotype was not determined. Two patients with haplotype 1 and one with haplotype 2 had a significant decline in serum immunoglobulin: one progressed from normal to IgAD associated with IgG subclass deficiencies, and two progressed from IgAD to CVID. Five of the seven patients with notable changing serum immunoglobulin levels have a family member with either IgAD or CVID. The findings suggest that familial, MHC-associated IgAD and CVID may be either progressive or reversible disorders, and emphasize the value of monitoring immunoglobulin levels in affected individuals and their family members.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182895      PMCID: PMC1904696          DOI: 10.1046/j.1365-2249.1997.3801278.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Genetics of IgA deficiency and common variable immunodeficiency.

Authors:  H W Schroeder
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

3.  Molecular analysis of B-cell differentiation in selective or partial IgA deficiency.

Authors:  T Asano; H Kaneko; T Terada; Y Kasahara; T Fukao; K Kasahara; N Kondo
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

4.  Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.

Authors:  Manfred Fliegauf; Vanessa L Bryant; Natalie Frede; Charlotte Slade; See-Tarn Woon; Klaus Lehnert; Sandra Winzer; Alla Bulashevska; Thomas Scerri; Euphemia Leung; Anthony Jordan; Baerbel Keller; Esther de Vries; Hongzhi Cao; Fang Yang; Alejandro A Schäffer; Klaus Warnatz; Peter Browett; Jo Douglass; Rohan V Ameratunga; Jos W M van der Meer; Bodo Grimbacher
Journal:  Am J Hum Genet       Date:  2015-08-13       Impact factor: 11.025

5.  Analysis of families with common variable immunodeficiency (CVID) and IgA deficiency suggests linkage of CVID to chromosome 16q.

Authors:  Alejandro A Schäffer; Jessica Pfannstiel; A David B Webster; Alessandro Plebani; Lennart Hammarström; Bodo Grimbacher
Journal:  Hum Genet       Date:  2005-11-22       Impact factor: 4.132

Review 6.  Study of patients with Hyper-IgM type IV phenotype who recovered spontaneously during late childhood and review of the literature.

Authors:  Neslihan Edeer Karaca; Anne Durandy; Nesrin Gulez; Guzide Aksu; Necil Kutukculer
Journal:  Eur J Pediatr       Date:  2011-01-28       Impact factor: 3.183

7.  Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes.

Authors:  H W Schroeder; Z B Zhu; R E March; R D Campbell; S M Berney; S A Nedospasov; R L Turetskaya; T P Atkinson; R C Go; M D Cooper; J E Volanakis
Journal:  Mol Med       Date:  1998-02       Impact factor: 6.354

8.  Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency.

Authors:  Asghar Aghamohammadi; Abolhasan Farhoudi; Mostafa Moin; Nima Rezaei; Ali Kouhi; Zahra Pourpak; Nima Yaseri; Masoud Movahedi; Mohammad Gharagozlou; Fariborz Zandieh; Fereshteh Yazadni; Saba Arshi; Iraj Mohammadzadeh; Bahram Mirsaeid Ghazi; Maryam Mahmoudi; Seyedamir Tahaei; Anna Isaeian
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

9.  Linkage of autosomal dominant common variable immunodeficiency to chromosome 5p and evidence for locus heterogeneity.

Authors:  D U Braig; A A Schäffer; E Glocker; U Salzer; K Warnatz; H H Peter; B Grimbacher
Journal:  Hum Genet       Date:  2003-02-06       Impact factor: 4.132

10.  Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia.

Authors:  R A al-Attas; A H Rahi
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.